Literature DB >> 26497991

Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers.

Renée Walhout1, Ruben Schmidt1, Henk-Jan Westeneng1, Esther Verstraete1, Meinie Seelen1, Wouter van Rheenen1, Marcel A de Reus1, Michael A van Es1, Jeroen Hendrikse1, Jan H Veldink1, Martijn P van den Heuvel1, Leonard H van den Berg2.   

Abstract

OBJECTIVE: To investigate possible effects of the C9orf72 repeat expansion before disease onset, we assessed brain morphology in asymptomatic carriers.
METHODS: Aiming to diminish the effects of genetic variation between subjects, apart from the C9orf72 repeat expansion, 16 carriers of the repeat expansion were compared with 23 noncarriers from the same large family with a history of amyotrophic lateral sclerosis (ALS). Cortical thickness, subcortical volumes, and white matter connectivity, as assessed from high-resolution T1-weighted and diffusion-weighted MRIs, were evaluated. For comparison, we included 14 C9orf72 carriers with ALS and 28 healthy, unrelated controls.
RESULTS: We found temporal, parietal, and occipital regions to be thinner (p < 0.05) and the left caudate and putamen to be smaller (p < 0.05) in asymptomatic carriers compared with noncarriers. Cortical thinning of the primary motor cortex and decreased connectivity of white matter pathways (global, corticospinal tract, and corpus callosum) were observed in patients with C9orf72-associated ALS, but not in asymptomatic carriers.
CONCLUSIONS: Asymptomatic C9orf72 carriers show cortical and subcortical differences compared with noncarriers from the same family, possibly effects of the C9orf72 repeat expansion on the brain. Of note, changes in the primary motor regions and motor-related tracts were found exclusively in patients with ALS, indicating that such motor changes may be a disease phenomenon.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26497991     DOI: 10.1212/WNL.0000000000002135

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

Review 1.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

Review 2.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 3.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

4.  Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.

Authors:  Tania F Gendron; Jeannie Chew; Jeannette N Stankowski; Lindsey R Hayes; Yong-Jie Zhang; Mercedes Prudencio; Yari Carlomagno; Lillian M Daughrity; Karen Jansen-West; Emilie A Perkerson; Aliesha O'Raw; Casey Cook; Luc Pregent; Veronique Belzil; Marka van Blitterswijk; Lilia J Tabassian; Chris W Lee; Mei Yue; Jimei Tong; Yuping Song; Monica Castanedes-Casey; Linda Rousseau; Virginia Phillips; Dennis W Dickson; Rosa Rademakers; John D Fryer; Beth K Rush; Otto Pedraza; Ana M Caputo; Pamela Desaro; Carla Palmucci; Amelia Robertson; Michael G Heckman; Nancy N Diehl; Edythe Wiggs; Michael Tierney; Laura Braun; Jennifer Farren; David Lacomis; Shafeeq Ladha; Christina N Fournier; Leo F McCluskey; Lauren B Elman; Jon B Toledo; Jennifer D McBride; Cinzia Tiloca; Claudia Morelli; Barbara Poletti; Federica Solca; Alessandro Prelle; Joanne Wuu; Jennifer Jockel-Balsarotti; Frank Rigo; Christine Ambrose; Abhishek Datta; Weixing Yang; Denitza Raitcheva; Giovanna Antognetti; Alexander McCampbell; John C Van Swieten; Bruce L Miller; Adam L Boxer; Robert H Brown; Robert Bowser; Timothy M Miller; John Q Trojanowski; Murray Grossman; James D Berry; William T Hu; Antonia Ratti; Bryan J Traynor; Matthew D Disney; Michael Benatar; Vincenzo Silani; Jonathan D Glass; Mary Kay Floeter; Jeffrey D Rothstein; Kevin B Boylan; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2017-03-29       Impact factor: 17.956

Review 5.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

Review 6.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

7.  Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.

Authors:  Anne Bertrand; Junhao Wen; Daisy Rinaldi; Marion Houot; Sabrina Sayah; Agnès Camuzat; Clémence Fournier; Sabrina Fontanella; Alexandre Routier; Philippe Couratier; Florence Pasquier; Marie-Odile Habert; Didier Hannequin; Olivier Martinaud; Paola Caroppo; Richard Levy; Bruno Dubois; Alexis Brice; Stanley Durrleman; Olivier Colliot; Isabelle Le Ber
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 8.  Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Authors:  Martin R Turner
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

9.  Structural brain correlates of cognitive and behavioral impairment in MND.

Authors:  Federica Agosta; Pilar M Ferraro; Nilo Riva; Edoardo G Spinelli; Adriano Chiò; Elisa Canu; Paola Valsasina; Christian Lunetta; Sandro Iannaccone; Massimiliano Copetti; Evelina Prudente; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

Review 10.  Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Authors:  Fabiola De Marchi; Claudia Carrarini; Antonio De Martino; Luca Diamanti; Antonio Fasano; Antonino Lupica; Mirella Russo; Simone Salemme; Edoardo Gioele Spinelli; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2021-03-27       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.